Results 31 to 40 of about 6,676 (255)

Cardiac Myosin-Binding Protein-C Phosphorylation and Cardiac Function [PDF]

open access: yesCirculation Research, 2005
The role of cardiac myosin binding protein-C (cMyBP-C) phosphorylation in cardiac physiology or pathophysiology is unclear. To investigate the status of cMyBP-C phosphorylation in vivo, we determined its phosphorylation state in stressed and unstressed mouse hearts.
Sakthivel, Sadayappan   +9 more
openaire   +2 more sources

Cardiac myosin-binding protein C (MYBPC3) in cardiac pathophysiology [PDF]

open access: yesGene, 2015
More than 350 individual MYPBC3 mutations have been identified in patients with inherited hypertrophic cardiomyopathy (HCM), thus representing 40–50% of all HCM mutations, making it the most frequently mutated gene in HCM. HCM is considered a disease of the sarcomere and is characterized by left ventricular hypertrophy, myocyte disarray and diastolic ...
Lucie, Carrier   +3 more
openaire   +2 more sources

Discovery of (S)-3′-hydroxyblebbistatin and (S)-3′-aminoblebbistatin : polar myosin II inhibitors with superior research tool properties [PDF]

open access: yes, 2017
In search of myosin II inhibitors with superior research tool properties, a chemical optimization campaign of the blebbistatin scaffold was conducted in this paper. (S)-Blebbistatin is the best known small-molecule inhibitor of myosin II ATPase activity.
Bracke, Marc   +6 more
core   +1 more source

Cardiac myosin binding protein C phosphorylation in cardiac disease [PDF]

open access: yesJournal of Muscle Research and Cell Motility, 2011
Perturbations in sarcomeric function may in part underlie systolic and diastolic dysfunction of the failing heart. Sarcomeric dysfunction has been ascribed to changes in phosphorylation status of sarcomeric proteins caused by an altered balance between intracellular kinases and phosphatases during the development of cardiac disease.
Kuster DWD   +5 more
openaire   +4 more sources

Aberrant splicing and expression of the non muscle myosin heavy-chain gene MYH14 in DM1 muscle tissues [PDF]

open access: yes, 2012
Myotonic dystrophy type 1 (DM1) is a complex multisystemic disorder caused by an expansion of a CTG repeat located at the 3' untranslated region (UTR) of DMPK on chromosome 19q13.3.
Angelini, C   +10 more
core   +1 more source

Serum Response Factor in muscle tissues: from development to ageing

open access: yesEuropean Journal of Translational Myology, 2016
Skeletal, cardiac and smooth muscle cells share various common characteristic features. During development the embryonic mesodermal layer contribute at different proportions to the formation of these tissues.
Dario Coletti   +4 more
doaj   +1 more source

Multiple myosin motors interact with sodium/potassium-ATPase alpha 1 subunits

open access: yesMolecular Brain, 2018
The alpha1 (α1) subunit of the sodium/potassium ATPase (i.e., Na+/K+-ATPase α1), the prototypical sodium pump, is expressed in each eukaryotic cell. They pump out three sodium ions in exchange for two extracellular potassium ions to establish a cellular ...
Bhagirathi Dash   +2 more
doaj   +1 more source

Cardiac Myosin Adenosinetriphosphatase Activity [PDF]

open access: yesCirculation Research, 1966
Cardiac myosin prepared by any one of a number of modifications of the basic Szent-Gyorgyi method and cardiac myosin prepared by the lithium chloride-ammonium sulfate technique differ in two important respects: 1) Szent-Gyorgyi-prepared myosin solutions are inhomogeneous by both chemical and immunologic criteria; 2) the ATPase activity of Szent-Gyorgyi-
R J, Luchi, E M, Kritcher
openaire   +2 more sources

Mouse models for the study of postnatal cardiac hypertrophy

open access: yesInternational Journal of Cardiology: Heart & Vasculature, 2015
The main objective of this study was to create a postnatal model for cardiac hypertrophy (CH), in order to explain the mechanisms that are present in childhood cardiac hypertrophy.
A. Del Olmo-Turrubiarte   +8 more
doaj   +1 more source

Differential expression of skeletal muscle genes following administration of clenbuterol to exercised horses. [PDF]

open access: yes, 2016
BackgroundClenbuterol, a beta2-adrenergic receptor agonist, is used therapeutically to treat respiratory conditions in the horse. However, by virtue of its mechanism of action it has been suggested that clenbuterol may also have repartitioning affects in
Chouicha, Nadira   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy